The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model

作者: Roseli García-Cruz , Maria Camats , George A. Calin , Chang-Gong Liu , Stefano Volinia

DOI: 10.1186/S12881-015-0184-Z

关键词:

摘要: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces G1/S phase delay, thereby maintaining cells in reversible quiescence state. When P21 is mutated tumour cells, protein also mutated. The mutation Q61L frequently detected different tumours, which acts as constitutive activator of Ras functions and considered to be strong activating mutant. Additionally, rare congenital disorder named Costello Syndrome, described children, mainly due G12S p19 p21 proteins, present 90 % Syndrome patients. Our aim better understand role proteins cancer development, concerning miRNAs expression. Total expression regulated were first analyzed human miRNA microarrays assays. Previously selected miRNAs, further developed cell lines containing mutants, that included mutant, with PCR Real-Time Taq Man Assays primers. This study describes how affects RNA world shows that: i) miR-342, miR-206, miR-330, miR-138 miR-99b are upregulated but not p19W164A mutant; ii) anti-miR-206 can restore G2 presence p19; iii) p21Q61L regulate their own splicing; iv) miR-206 differentially v) P19G12S mutants show clear upregulation miR-374, miR-126, miR-335 let-7. These results allow us conclude plays an important open up new line consequences this on syndrome. Furthermore, they suggest oncogenes may have sufficiently impact promote development numerous cancers.

参考文章(39)
Kyriacos Felekkis, Evi Touvana, Ch Stefanou, C Deltas, None, microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia. ,vol. 14, pp. 236- 240 ,(2010)
Sohail F. Tavazoie, Claudio Alarcón, Thordur Oskarsson, David Padua, Qiongqing Wang, Paula D. Bos, William L. Gerald, Joan Massagué, Endogenous human microRNAs that suppress breast cancer metastasis Nature. ,vol. 451, pp. 147- 152 ,(2008) , 10.1038/NATURE06487
R Garzon, F Pichiorri, T Palumbo, M Visentini, R Aqeilan, A Cimmino, H Wang, H Sun, S Volinia, H Alder, G A Calin, C-G Liu, M Andreeff, C M Croce, MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia Oncogene. ,vol. 26, pp. 4148- 4157 ,(2007) , 10.1038/SJ.ONC.1210186
C. M. Niemeyer, RAS diseases in children Haematologica. ,vol. 99, pp. 1653- 1662 ,(2014) , 10.3324/HAEMATOL.2014.114595
Shin Muraoka, Fumi Shima, Mitsugu Araki, Tomoko Inoue, Akiko Yoshimoto, Yuichi Ijiri, Nobuaki Seki, Atsuo Tamura, Takashi Kumasaka, Masaki Yamamoto, Tohru Kataoka, Crystal structures of the state 1 conformations of the GTP-bound H-Ras protein and its oncogenic G12V and Q61L mutants FEBS Letters. ,vol. 586, pp. 1715- 1718 ,(2012) , 10.1016/J.FEBSLET.2012.04.058
S. Vimalraj, P. J. Miranda, B. Ramyakrishna, N. Selvamurugan, Regulation of breast cancer and bone metastasis by microRNAs. Disease Markers. ,vol. 35, pp. 369- 387 ,(2013) , 10.1155/2013/451248
Ingo Büssing, Frank J. Slack, Helge Großhans, let-7 microRNAs in development, stem cells and cancer Trends in Molecular Medicine. ,vol. 14, pp. 400- 409 ,(2008) , 10.1016/J.MOLMED.2008.07.001
Rubén Hernández-Alcoceba, L Del Peso, Juan Carlos Lacal*, The Ras family of GTPases in cancer cell invasion. Cellular and Molecular Life Sciences. ,vol. 57, pp. 65- 76 ,(2000) , 10.1007/S000180050499
N. Mosakhani, R. Räty, A. Tyybäkinoja, M.-L. Karjalainen-Lindsberg, E. Elonen, S. Knuutila, MicroRNA Profiling in Chemoresistant and Chemosensitive Acute Myeloid Leukemia Cytogenetic and Genome Research. ,vol. 141, pp. 272- 276 ,(2013) , 10.1159/000351219